Get In Touch

Diabetes is a lifelong, chronic disease caused by excessive levels of glucose in the blood primarily due to lack or insufficiency of insulin hormone to metabolize the glucose in the blood. This accumulated glucose in the blood does not reach body cells and severely affects multiple organs such as kidneys, eyes, nerves, blood vessels, and heart. Diabetic nephropathy is one of the common diabetic kidney diseases characterized by the presence of proteinuria >0.5 g/24 h, reduction in glomerular filtration rate, and high blood pressure. Obesity, hypertension, high lipid, and high blood glucose levels due to diabetes can damage the part of kidney which filters blood and is associated with increased cardiovascular mortality. If left untreated, it could lead to chronic kidney disease or failure. Diabetic nephropathy can develop in any individual suffering from type 1 or type 2 diabetes. This disease is the leading cause of kidney failure across the globe. 

Rise in prevalence of diabetes across the globe is anticipated to drive the diabetic nephropathy market. According to the National Center for Biotechnology Information, 126 million people were affected by diabetic nephropathy in 2010; more than 191 million people are likely to be affected by diabetic nephropathy by 2030. According to the U.S. National Health and Nutrition Examination Survey (NHANES) 2009 to 2014, prevalence of diabetic nephropathy was 26.2% among adults with diabetes, taken into account albuminuria persistence. Increase in geriatric population, high prevalence of obesity, and rise in sedentary lifestyle are the key factors propelling the global diabetic nephropathy market. Furthermore, increase in awareness about the early detection of diabetic nephropathy among diabetic patients across the globe, improvement in health care facilities in emerging and developed countries, and availability of multiple treatment options with advanced technology augment the market. However, negligence toward diabetic nephropathy, poor planning of diabetic nephropathy treatment in low income countries, and lack of skilled professionals for treatment of diabetic nephropathy in emerging and less developed countries are the key factors restraining the market. 

The global diabetic nephropathy market can be segmented based on indication, type of treatment, diagnosis type, end-user, and region. In terms of indication, the market can be bifurcated into type-1 diabetes and type-2 diabetes. Based on type of treatment, the global diabetic nephropathy market can be classified into diuretics, antioxidant inflammation modulator, angiotensin receptor blockers, angiotensin-converting enzyme inhibitors (ACE inhibitors), renin inhibitors, calcium channel blockers, and others (G protein-coupled receptors and monocyte chemoattractant protein-1). The ACE inhibitors segment held major share of the global diabetic nephropathy market in 2017. This is attributed to safety and efficacy for specific symptoms related to diabetic nephropathy. In terms of diagnosis type, the market can be categorized into imaging tests, renal function testing, urine test, blood test, and renal biopsy. Based on end-user, the global diabetic nephropathy market can be divided into hospitals, clinics, diagnostic centers, and research institutes. Most of the pipeline drugs for diabetic nephropathy are in the pre-clinical stage of development and phase II stage of development. The pipeline drugs for diabetic nephropathy consist of nearly 68 drug candidates in different stages of development. 

In terms of region, the global diabetic nephropathy market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period owing to rise in prevalence of diabetic nephropathy, well-established health care infrastructure, and increase in awareness about diabetic nephropathy among diabetic patients. Asia Pacific is anticipated to be the second leading market for diabetic nephropathy treatment due to increase in diabetic population and changing lifestyles of people. The market in Asia Pacific is expected to expand at the highest CAGR during the forecast period. Middle East & Africa is likely to be the least attractive market primarily due to the presence of low income groups, lack of skilled personnel, and poor access to health care facilities. 

Key players operating in the global diabetic nephropathy market are AstraZeneca plc, Bayer AG, Novartis AG., Allergan, Inc., Boehringer Ingelheim GmbH, Daiichi Sankyo Co. Ltd., Gilead Sciences, Inc., Johnson & Johnson, Novo Nordisk AS, Regeneron Pharmaceuticals, Inc., and Merck & Co, Inc. New business development through acquisitions & mergers, and establishment of subsidiaries in emerging economies are the common trends in the global diabetic nephropathy market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Diabetic Nephropathy Market

Pre Book